Pain Management Therapeutics Market to Expand at 2.8% CAGR, Surpassing US$ 110 Bn by 2035 | TMR

Global pain management therapeutics market faces growth hurdles from opioid crisis, side effects, and high costs of advanced treatments.

WILMINGTON, DE, UNITED STATES, August 22, 2025 /EINPresswire.com/ -- The global pain management therapeutics market is undergoing significant transformation as rising incidences of chronic pain conditions and innovations in drug delivery systems reshape treatment options. Valued at US$ 81.2 billion in 2024, the market is projected to grow steadily at a CAGR of 2.8% from 2025 to 2035, ultimately surpassing US$ 110.0 billion by the end of 2035.

The burden of chronic pain including arthritis, neuropathic pain, fibromyalgia, and cancer-related pain has intensified worldwide, driven by aging demographics, sedentary lifestyles, and an increasing prevalence of comorbidities such as diabetes and obesity. Against this backdrop, pharmaceutical and biotech companies are accelerating the development of safer, effective, and long-lasting therapies, positioning the pain management therapeutics market for long-term resilience.

Market Overview: The pain management therapeutics market encompasses a wide range of pharmacological treatments, including opioids, NSAIDs, anticonvulsants, antidepressants, anesthetics, and biologics, along with non-pharmacological interventions. North America currently dominates the global market, benefitting from advanced healthcare infrastructure and widespread access to treatment, while emerging regions such as Asia-Pacific, Latin America, and Africa present untapped opportunities due to expanding healthcare systems and growing awareness.
The opioid crisis continues to challenge the sector, with governments imposing strict regulatory oversight. As a result, there is a rising emphasis on non-opioid alternatives, novel delivery systems (transdermal patches, extended-release formulations), biologics, and wearable pain management technologies.

Key Drivers of Market Growth

1. Rising Prevalence of Chronic Pain Conditions
o Over 20.9% of U.S. adults (51.6 million people) suffered from chronic pain in 2021, with 6.9% (17.1 million people) reporting high-impact chronic pain, according to the CDC.
o Globally, the increase in aging populations, coupled with lifestyle-related conditions, is contributing to a growing demand for effective pain therapeutics.
2. Innovations in Drug Formulations and Delivery Methods
o Sustained-release formulations, transdermal patches, liposomal delivery, and targeted drug release systems are improving efficacy and patient compliance while reducing side effects.
o Gene therapies, injectable biologics, and nanoparticle-based solutions are advancing personalized treatment strategies.
3. Paradigm Shift Toward Multimodal Pain Management
o Clinicians are increasingly adopting multimodal pain management approaches that combine pharmacological and non-pharmacological therapies to minimize opioid dependency.
o This trend is driving demand for diverse therapeutic classes and integrated pain management solutions.

Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1059

Key Players and Industry Leaders

The competitive landscape is dominated by global pharmaceutical giants, regional players, and emerging biotech firms. Key players include:
• Pfizer Inc.
• Eli Lilly and Company
• GSK plc
• Merck & Co., Inc.
• Novartis AG
• Johnson & Johnson Services, Inc.
• Abbott
• Teva Pharmaceutical Industries Ltd.
• Mallinckrodt Pharmaceuticals
• AstraZeneca
• Bayer AG
• Sanofi
• Viatris Inc.
• Haleon plc
• Lupin Limited
These companies are investing heavily in R&D, strategic collaborations, acquisitions, and product innovation to capture market share.

Recent Developments

• January 2025 – Vertex Pharmaceuticals received FDA approval for JOURNAVX (suzetrigine), a non-opioid, NaV1.8 pain signal inhibitor for adults with moderate-to-severe acute pain.
• February 2025 – Allay Therapeutics initiated Phase 2b trials for ATX101, an extended-release analgesic designed to reduce post-surgical opioid use in knee replacement patients.
• Major industry players are focusing on abuse-deterrent opioid formulations and extended-release drug designs to mitigate addiction risks while ensuring effective pain control.

Market Opportunities and Challenges

Opportunities:
• Expansion of healthcare access in emerging economies.
• Growth in personalized medicine and biomarker-based therapies.
• Rising adoption of non-opioid pain solutions, including biologics and neurostimulation devices.
• Increasing digital health integration, with wearable devices and remote pain monitoring.

Challenges:
• Opioid misuse and addiction, leading to stringent regulatory frameworks.
• High costs of biologics and neuromodulation devices, limiting accessibility in low-income regions.
• Potential side effects of commonly prescribed therapeutics (NSAIDs, gabapentinoids, patches).

Latest Market Trends

• Shift from opioids to safer alternatives such as biologics, anticonvulsants, and non-opioid analgesics.
• Wearable devices and digital therapeutics enabling personalized and real-time pain monitoring.
• Increasing role of artificial intelligence (AI) in drug discovery and patient-specific pain management strategies.
• Adoption of gene therapy and regenerative medicine for chronic pain and neuropathic conditions.

Future Outlook

The pain management therapeutics market will continue expanding steadily, driven by innovations in non-opioid solutions and widening access in developing markets. By 2035, revenues are expected to exceed US$ 110 billion, supported by:
• Personalized medicine approaches offering tailored solutions.
• Digital health ecosystems integrating wearable technologies with traditional treatments.
• Healthcare policy reforms encouraging opioid alternatives.
North America will remain the global leader, while Asia-Pacific will emerge as the fastest-growing region due to large patient pools, rising awareness, and increasing government healthcare spending.

Market Segmentation

By Drug Class:
• Opioids
• NSAIDs
• Anticonvulsants
• Antidepressants
• Anesthetics
• Anti-migraine Agents
• Others

By Drug Type:
• Over-the-Counter (OTC) Drugs
• Prescription Drugs

By Pain Type:
• Acute Pain
• Chronic Pain

By Route of Administration:
• Oral
• Parenteral
• Topical
• Others

By Indication:
• Arthritis
• Cancer Pain
• Fibromyalgia
• Chronic Back Pain
• Neuropathic Pain
• Post-operative Pain
• Migraines
• Muscle Sprain/Strain
• Others

By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Regional Insights

• North America: Leading market due to advanced healthcare systems, large chronic pain patient pool, and high adoption of novel therapies.
• Europe: Strong growth driven by supportive reimbursement policies and rising elderly population.
• Asia-Pacific: Poised for fastest growth, fueled by rising healthcare spending, larger populations, and greater access to treatment.
• Latin America & Middle East/Africa: Increasing awareness and healthcare expansion present untapped opportunities, though cost barriers remain.

Why Buy This Report?

• Comprehensive Market Coverage: Includes quantitative and qualitative analysis with 2020–2023 historical data and forecasts up to 2035.
• Competitive Landscape Insights: Detailed profiles of leading players, recent strategies, and product portfolios.
• Strategic Decision Support: Identifies emerging opportunities, challenges, and trends shaping the future of pain management therapeutics.
• Segmentation & Regional Analysis: Offers in-depth insights across drug classes, indications, and geographies.
• Forward-looking Perspective: Helps stakeholders anticipate regulatory, technological, and demographic shifts impacting the market.

Browse More Trending Research Reports:

Non-opioid Pain Patch Market: https://www.transparencymarketresearch.com/non-opioid-pain-patch-market.html
Neuropathic Pain Management Market: https://www.transparencymarketresearch.com/neuropathic-pain-management-market.html
Topical Pain Relief Market: https://www.transparencymarketresearch.com/topical-pain-relief-market.html
Joint Pain Injections Market: https://www.transparencymarketresearch.com/joint-pain-injection-market.html
Complex Regional Pain Syndrome (CRPS) Therapeutics Market: https://www.transparencymarketresearch.com/complex-regional-pain-syndrome-therapeutics.html
Topical Pain Management Therapeutics in Sports Medicine Market: https://www.transparencymarketresearch.com/topical-pain-management-therapeutics-sports-medicine-market.html
PCSK9 Inhibitor Market: https://www.transparencymarketresearch.com/pcsk9-inhibitors-market.html
Pancreatic Cancer Treatment Market: https://www.transparencymarketresearch.com/pancreatic-cancer-treatment-market.html
Paroxysmal Nocturnal Hemoglobinuria Market: https://www.transparencymarketresearch.com/paroxysmal-nocturnal-hemoglobinuria-market.html
Live Biotherapeutics Market: https://www.transparencymarketresearch.com/live-biotherapeutics-market.html
Bromelain Market: https://www.transparencymarketresearch.com/bromelain-market.html
Peptide Therapeutics Market: https://www.transparencymarketresearch.com/peptide-therapeutics-market.html
Biologics Market: https://www.transparencymarketresearch.com/global-biologics-market.html
Active Pharmaceutical Ingredients (API) Market: https://www.transparencymarketresearch.com/active-pharmaceutical-ingredients.html
Psoriasis Treatment Market: https://www.transparencymarketresearch.com/psoriasis-treatment-market.html
Addiction Treatment Market: https://www.transparencymarketresearch.com/addiction-treatment-market.html
Ophthalmic Drugs Market: https://www.transparencymarketresearch.com/ophthalmic-drugs-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

Atil Chaudhari
Transparency Market Research Inc.
+1 518-618-1030
email us here
Visit us on social media:
LinkedIn
Instagram
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.